http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q#Head
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q#assertion
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q#provenance
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q#pubinfo
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q#assertion
http://purl.obolibrary.org/obo/DOID_9952
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_9952
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00997
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q#association
http://www.w3.org/2000/01/rdf-schema#label
doxorubicin hydrochloride hcl for injection is an anthracycline topoisomerase ii inhibitor indicated as a component of multiagent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer 1 1 for the treatment of acute lymphoblastic leukemia acute myeloblastic leukemia hodgkin lymphoma non hodgkin lymphoma metastatic breast cancer metastatic wilms tumor metastatic neuroblastoma metastatic soft tissue sarcoma metastatic bone sarcomas metastatic ovarian carcinoma metastatic transitional cell bladder carcinoma metastatic thyroid carcinoma metastatic gastric carcinoma metastatic bronchogenic carcinoma 1 2 doxorubicin hcl for injection is indicated as a component of multi agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer see clinical studies 14 doxorubicin hcl for injection is indicated for the treatment of acute lymphoblastic leukemia acute myeloblastic leukemia hodgkin lymphoma non hodgkin lymphoma nhl metastatic breast cancer metastatic wilms tumor metastatic neuroblastoma metastatic soft tissue sarcoma metastatic bone sarcoma metastatic ovarian carcinoma metastatic transitional cell bladder carcinoma metastatic thyroid carcinoma metastatic gastric carcinoma metastatic bronchogenic carcinoma
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB00997
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q#provenance
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q#pubinfo
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q#sig
http://purl.org/nanopub/x/hasSignature
Kud5E7ZvOKs/qK6dLZb69Nu/SVxDIfH5tkXFPj7/UG04iEDIDhF2BURrZvAsUETwXvE8CfPzESObOFqhDm990cfEBRwU+dr0nYzoV7sH5HKTrrIigvgji6Xxhw6GdFpmkGVtVJZ/mfYc8OlA4WBmAkAhzgXSsKVIjHgAuin4ops=
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q
http://purl.org/dc/terms/created
2021-06-27T20:20:30.572+02:00
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAxNy2IjLKTlMmzqnkMiGI_wimOCnHth-f7on4R_p3R4Q
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs